The New England Compounding Center (NECC) facility has problems maintaining its clean rooms, the Food and Drug Administration (FDA) informed as it released a copy of the FDA Form 483 to the NECC. The FDA says it listed a number of "observations", including contaminated products. FDA inspectors visited NECC for a total of seven days from October 1st to 26th after the company had recalled a steroid medication. The clean room is an enclosed space that is supposed to contain a controlled environment with minimum levels of airborne particles and surface contaminants...
More...
More...